Long intergenic non-protein coding RNA 1142 (LINC01142)

Long intergenic non-protein coding RNA 1142 (LINC01142) is a member of the long intergenic non-coding RNA (lincRNA) family, a group of RNA molecules greater than 200 nucleotides in length that do not overlap protein-coding regions and lack protein-coding potential[1][5]. LincRNAs participate in diverse regulatory functions, including transcriptional and epigenetic regulation, and often act by modulating gene expression through interactions with chromatin remodeling complexes, transcription factors, or as molecular scaffolds or sponges for microRNAs[3][5]. While many lincRNAs have been implicated in cellular processes such as cell cycle control or cell differentiation, specific biological functions and clinical significance of LINC01142 have not yet been well characterized in the literature[1]. There are no reported associations with drugs, biomarkers, or prominent disease roles for LINC01142 based on current public knowledge and gene databases[1][3][5]. Key context: - LINC01142 is not a receptor, enzyme, transporter, or a typical therapeutic target as of current evidence[1][5]. - Its main characteristic is as a non-coding RNA gene with poorly defined or unknown biological role compared to more studied lncRNAs such as HOTAIR or LINC01133[1][5]. - There is no evidence of approved or investigational drugs directly targeting LINC01142. - No evidence exists to support its use as a biomarker or its involvement in disease pathogenesis, based on currently available literature and gene data[1][5]. If you are referencing LINC01142 in the context of therapeutic development or disease association, further empirical research and validation would be required.

Other names

LINC01142long intergenic non-coding RNA 1142